JOHANNA CHRISTENSEN: Open Payments
NPI 1902146889 · NEW YORK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$10,718 in 21 payments from 6 companies in 2025. Trend: 2023 $50 · 2024 $8,997 · 2025 $10,718
Consulting: $9,465Food & beverage: $1,254
| Company | Payments | Amount |
|---|---|---|
| Apellis Pharmaceuticals, Inc. | 10 | $7,486 |
| Veloxis Pharmaceuticals, Inc. | 6 | $3,022 |
| GENZYME CORPORATION | 1 | $91 |
| Novartis Pharmaceuticals Corporation | 2 | $84 |
| Alexion Pharmaceuticals, Inc. | 1 | $21 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $14 |
Products named: ENVARSUS, Empaveli, Vanrafia, ULTOMIRIS, JARDIANCE.
Industry payments across NY — which companies pay providers there.
